Jan Kamps

Jan Kamps is a Professor in the Department of Nanotechnology and Biophysics in Medicine (NANOBIOMED) at the University Medical Center Groningen (UMCG). His primary affiliation is with the Faculty of Medical Sciences, where he focuses on advanced drug delivery systems and nanomedicine applications. His work contributes to UN Sustainable Development Goals related to health and innovation.

Research interests center on lipid-based nanoparticles for targeted therapy, endothelial cell biology, and inflammatory processes in sepsis. He has published 92+ research outputs, with recent studies emphasizing E-selectin-mediated drug delivery for Fabry disease and mechanistic insights into sepsis-induced vascular inflammation.

His lab explores liposomal systems like MC3/SAINT-O-Somes for siRNA delivery and investigates metabolic toxicity of fatty acids on endothelial cells. Collaborations involve multidisciplinary teams addressing vascular biology and nanotechnology challenges in medicine.